BIOCRYST PHARMACEUTICALS, INC. 15,533,981 Shares of Common Stock (par value $0.01 per share) Underwriting AgreementUnderwriting Agreement • September 15th, 2017 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 15th, 2017 Company Industry Jurisdiction